Angiotensin-converting enzyme 2 (ACE2) has been identified as the receptor for SARS-CoV-2, and it has been suggested that differential levels of ACE2 in the cardiac and pulmonary tissues of younger versus older adults may be at least partially responsible for the spectrum of disease virulence observed among patients with COVID-19 [10]. The gene discussed is ACE2; the disease is COVID-19.